GREENWICH LIFESCIENCES, INC. (GLSI)
Clinical trial NCT05232916 updates: 1. start date: 2022-08-11 → 2022-12-16 2. completion date: 2026-12-01 → 2031-12-01 3. primary completion date: 2026-12-01 → 2031-12-01 4. enrollment: 750 → 2250 participants
Clinical trial NCT05232916 updates: 1. start date: 2022-08-11 → 2022-12-16 2. completion date: 2026-12-01 → 2031-12-01 3. primary completion date: 2026-12-01 → 2031-12-01 4. enrollment: 750 → 2250 participants
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical